Opinion|Videos|July 3, 2024

Investigational Therapies Paving New PNH Treatment Pathways

Dr Haumschild continues leading a discussion surrounding potential treatment advancements in the PNH landscape.

Video content above is prompted by the following:

  • Looking towards the future, what advancements do you anticipate in the treatment landscape for PNH and other complement-driven rare diseases, particularly in relation to investigational therapeutics targeting the alternative pathway?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo